Evidence map›Paper›PMID 42752905›Full record

ReviewPhytotherapy research : PTR2026

Natural Polysaccharides for Rheumatoid Arthritis Therapy: Mechanism, Drug Delivery and Clinical Application.

Luxin Li, Junnan Li, Guangzhi Li, Lili Huang, Tiantian Wen, Yanying Li, Yan Sun, Zhenqiang Liu, Qingshan Chen, Lili Zhang and 5 more

Abstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Luxin LiKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Junnan LiKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Guangzhi LiKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Lili HuangKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.ORCID https://orcid.org/0000-0003-3937-2891
Tiantian WenKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Yanying LiKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Yan SunKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Zhenqiang LiuKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.
Qingshan ChenCollege of Agriculture, Northeast Agricultural University, Harbin, China.
Lili ZhangCollege of Agriculture, Northeast Agricultural University, Harbin, China.
Tiangang LuHeilongjiang Jiren Pharmaceutical Co., Ltd, Harbin, China.
Ruiyan WuHeilongjiang Jiren Pharmaceutical Co., Ltd, Harbin, China.
Haixue KuangKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.ORCID https://orcid.org/0000-0003-0535-2761
Xiaochi MaSecond Affiliated Hospital, Dalian Medical University, Dalian, China.
Yan LiuKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin, China.ORCID https://orcid.org/0000-0003-4910-775X

Funding

Heilongjiang Chunyan Innovation Team Program CYQN24014Heilongjiang Province "Double First-Class" Discipline Collaborative Innovation Achievements Construction Project LJGXCG2024-F28National Key Research and Development Program of China 2024YFC3506600National Natural Science Foundation for Young Scholars of China 82505001National Natural Science Foundation of China U22A20370
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized primarily by chronic synovitis. Clinically, RA manifests as joint pain, swelling, and functional impairment caused by persistent synovial inflammation. Additionally, RA can involve vital organs, including the cardiovascular and respiratory systems, thereby significantly compromising patients' quality of life and increasing the risk of disability. In recent years, natural polysaccharides have attracted increasing attention in research on RA prevention and treatment because of their multi-target regulatory effects, high bioactivity, and low-toxicity. Natural polysaccharides can ameliorate the pathological progression of RA through various mechanisms, including modulating immune balance, suppressing inflammatory responses, alleviating oxidative stress, inhibiting the abnormal proliferation of synovial fibroblasts, and regulating gut microbiota. This review systematically summarizes the pharmacodynamic basis and molecular mechanisms underlying the anti-RA effects of natural polysaccharides reported since 2000, with particular emphasis on recent advances in novel drug delivery technologies and a critical evaluation of clinical application studies. These findings aim to provide scientific evidence and theoretical support for developing new therapeutic strategies involving natural polysaccharides for RA treatment.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidPolysaccharidesAnimalsDrug Delivery SystemsHumansOxidative StressAntirheumatic AgentsPolysaccharidesclinical applicationdrug deliverymechanismpolysaccharidesrheumatoid arthritis

Identifiers

PMID42752905
PMCPMC13753661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.